2012年7月21日星期六

Bevacizumab (Avastin): An anti-angiogenic drug associated with osteonecrosis of the jaw.

Related Articles

Bevacizumab (Avastin): An anti-angiogenic drug associated with osteonecrosis of the jaw.

Gen Dent. 2011 Nov-Dec;59(6):410-3

Authors: Wynn RL

PMID: 22313910 [PubMed - indexed for MEDLINE]

SEE HERE CLICK HERE

没有评论:

发表评论